Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,364 public trials 2,842 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

NCT04285086

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • Washington University School of Medicine - Division of Oncology St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
View all 67 locations
View Trial Details
Active, Not Recruiting

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

NCT06099236

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Chongqing, Sichuan, China
  • Research Site Anhui, China
  • Research Site Beijing, China
View all 26 locations
View Trial Details
Active, Not Recruiting

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of California, Davis - Health Systems Sacramento, California, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT05143840

Conditions
Adult CML, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05083169

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 176 locations
View Trial Details

Related conditions